Terms: = Colorectal cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Treatment
18 results:
1. colorectal cancer subtyping and prognostic model construction based on interleukin-related genes.
Song J; Chen J; Chen Y; Wang Y; Zheng L; Yu H; Chen C
Physiol Genomics; 2024 May; 56(5):367-383. PubMed ID: 38073490
[TBL] [Abstract] [Full Text] [Related]
2. Discovery of a novel oral type Ⅰ CDK8 inhibitor against acute myeloid leukemia.
Zhang XX; Yan YY; Ma X; Xiao Y; Lei CC; Wang YM; Liu C; Wang Q; Zhang XT; Cheng WD; Liu XH
Eur J Med Chem; 2023 May; 251():115214. PubMed ID: 36889252
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of GZ17-6.02 resistance.
Booth L; West C; Von Hoff D; Dent P
Anticancer Drugs; 2022 Jun; 33(5):415-423. PubMed ID: 35276694
[TBL] [Abstract] [Full Text] [Related]
4. LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
Wang H; Liu Z; Guan L; Li J; Chen S; Yu W; Lai M
Pharmacol Res; 2020 Mar; 153():104661. PubMed ID: 31982491
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting stat5 and STAT6.
Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
[TBL] [Abstract] [Full Text] [Related]
6. PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling.
Xu J; Wu W; Tang Y; Lin Y; Xue Y; Hu J; Lin D
Aging (Albany NY); 2019 Sep; 11(18):7817-7829. PubMed ID: 31546234
[TBL] [Abstract] [Full Text] [Related]
7. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
[No Abstract] [Full Text] [Related]
8. JAK/stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer.
Giordano G; Parcesepe P; D'Andrea MR; Coppola L; Di Raimo T; Remo A; Manfrin E; Fiorini C; Scarpa A; Amoreo CA; Conciatori F; Milella M; Caruso FP; Cerulo L; Porras A; Pancione M
J Exp Clin Cancer Res; 2019 Jan; 38(1):28. PubMed ID: 30670049
[TBL] [Abstract] [Full Text] [Related]
9. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.
Bruno A; Bassani B; D'Urso DG; Pitaku I; Cassinotti E; Pelosi G; Boni L; Dominioni L; Noonan DM; Mortara L; Albini A
FASEB J; 2018 Oct; 32(10):5365-5377. PubMed ID: 29763380
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of new benzensulfonamide derivatives as tripedal STAT3 inhibitors.
Guo J; Yu W; Cai G; Zhang W; Li S; Zhu J; Song D; Kong L
Eur J Med Chem; 2018 May; 151():752-764. PubMed ID: 29674294
[TBL] [Abstract] [Full Text] [Related]
11. Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance.
Zhou W; Sun W; Yung MMH; Dai S; Cai Y; Chen CW; Meng Y; Lee JB; Braisted JC; Xu Y; Southall NT; Shinn P; Huang X; Song Z; Chen X; Kai Y; Cai X; Li Z; Hao Q; Cheung ANY; Ngan HYS; Liu SS; Barak S; Hao J; Dai Z; Tzatsos A; Peng W; Pei H; Han Z; Chan DW; Zheng W; Zhu W
Oncogene; 2018 Jul; 37(29):3981-3997. PubMed ID: 29662190
[TBL] [Abstract] [Full Text] [Related]
12. DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation.
Xiao Q; Wu J; Wang WJ; Chen S; Zheng Y; Yu X; Meeth K; Sahraei M; Bothwell ALM; Chen L; Bosenberg M; Chen J; Sexl V; Sun L; Li L; Tang W; Wu D
Nat Med; 2018 Mar; 24(3):262-270. PubMed ID: 29431745
[TBL] [Abstract] [Full Text] [Related]
13. STAT3 activation in infection and infection-associated cancer.
Lu R; Zhang YG; Sun J
Mol Cell Endocrinol; 2017 Aug; 451():80-87. PubMed ID: 28223148
[TBL] [Abstract] [Full Text] [Related]
14. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract] [Full Text] [Related]
15. Functions and regulation of MUC13 mucin in colon cancer cells.
Gupta BK; Maher DM; Ebeling MC; Stephenson PD; Puumala SE; Koch MR; Aburatani H; Jaggi M; Chauhan SC
J Gastroenterol; 2014 Oct; 49(10):1378-91. PubMed ID: 24097071
[TBL] [Abstract] [Full Text] [Related]
16. Clostridium difficile toxin A inhibits erythropoietin receptor-mediated colonocyte focal adhesion through inactivation of Janus Kinase-2.
Nam ST; Seok H; Kim DH; Nam HJ; Kang JK; Eom JH; Lee MB; Kim SK; Park MJ; Chang JS; Ha EM; Shong KE; Hwang JS; Kim H
J Microbiol Biotechnol; 2012 Dec; 22(12):1629-35. PubMed ID: 23221524
[TBL] [Abstract] [Full Text] [Related]
17. stat5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells.
Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y
Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509
[TBL] [Abstract] [Full Text] [Related]
18. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract] [Full Text] [Related]
